401 Avsnitt

  1. Episode 183: Oliver Sartor - The Uromigos Legends Series

    Publicerades: 2022-07-18

  2. Episode 182: ASCO Kidney Cancer Guidelines

    Publicerades: 2022-07-11

  3. Episode 181: Relapsed Germ Cell Tumours

    Publicerades: 2022-06-27

  4. Episode 180: Enzalutamide vs active surveillance in early prostate cancer

    Publicerades: 2022-06-20

  5. Episode 179: PSMA PET for Lutetium-177 in prostate cancer

    Publicerades: 2022-06-20

  6. Episode 178: ASCO 2022: Germline variants in men of African descent with prostate cancer

    Publicerades: 2022-06-07

  7. Episode 177: ASCO 2022: ENZAMET survival update

    Publicerades: 2022-06-05

  8. Episode 176: ASCO 2022: HER-2 ADCs in Bladder Cancer

    Publicerades: 2022-06-05

  9. Episode 175: ASCO 2022: Targeting the microbiome in renal cancer

    Publicerades: 2022-06-04

  10. Episode 174: ASCO 2022: Cell free DNA as a biomarker in bladder cancer

    Publicerades: 2022-06-03

  11. Episode 173: ASCO 2022: The Atlantis Trial - maintenance cabozantinib in bladder cancer

    Publicerades: 2022-06-03

  12. Episode 172: ASCO 2022: Adjuvant everolimus in renal cancer

    Publicerades: 2022-06-03

  13. Episode 171: Antibody drug conjugates in bladder cancer: managing adverse effects

    Publicerades: 2022-05-23

  14. Episode 170: APCCC Meeting Summary

    Publicerades: 2022-05-16

  15. Episode 169: The Uromigos Paper of the Month - Novel neoadjuvant approaches in UC

    Publicerades: 2022-05-09

  16. Episode 168: Mechanisms of response to PD1 therapy in renal cancer

    Publicerades: 2022-05-02

  17. Episode 167: Highlights from EIKCS oral session

    Publicerades: 2022-04-22

  18. Episode 166: Prostate cancer debate: doublet vs triplet first line therapy

    Publicerades: 2022-04-18

  19. Episode 165: Paper of the Month - ENZAMET quality of life data

    Publicerades: 2022-04-06

  20. Episode 164: Paper of the Month - what can we learn from R3 ipilimumab/nivolumab in gastric cancer

    Publicerades: 2022-04-01

12 / 21

Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is a Professor of Cancer Research and Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London

Visit the podcast's native language site